This content is only available within our institutional offering.
15 Nov 2019
LIBERUM: European Healthcare investor feedback - What's hot, what's not and which stocks are the most divisive?
AstraZeneca PLC (AZN:LON), 10,689 | Bayer AG (BAYN:ETR), 0 | GSK plc (GSK:LON), 1,709 | Novartis AG (NOVN:SWX), 0 | Novo Nordisk A/S Class B (NOVO.B:CSE), 0 | Roche Holding Ltd Dividend Right Cert. (ROG:SWX), 0 | Sanofi (SAN:PAR), 0 | Cello Health (CLL:LON), 0 | Huntsworth (HNT:LON), 0 | Futura Medical plc (FUM:LON), 40.1 | Malin Corporation PLC (MLC:DUB), 0 | PureTech Health PLC (PRTC:LON), 224 | Spire Healthcare Group PLC (SPI:LON), 234 | Oxford BioMedica plc (OXB:LON), 201
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: European Healthcare investor feedback - What's hot, what's not and which stocks are the most divisive?
AstraZeneca PLC (AZN:LON), 10,689 | Bayer AG (BAYN:ETR), 0 | GSK plc (GSK:LON), 1,709 | Novartis AG (NOVN:SWX), 0 | Novo Nordisk A/S Class B (NOVO.B:CSE), 0 | Roche Holding Ltd Dividend Right Cert. (ROG:SWX), 0 | Sanofi (SAN:PAR), 0 | Cello Health (CLL:LON), 0 | Huntsworth (HNT:LON), 0 | Futura Medical plc (FUM:LON), 40.1 | Malin Corporation PLC (MLC:DUB), 0 | PureTech Health PLC (PRTC:LON), 224 | Spire Healthcare Group PLC (SPI:LON), 234 | Oxford BioMedica plc (OXB:LON), 201
- Published:
15 Nov 2019 -
Author:
Graham Doyle | Alistair Campbell -
Pages:
3